Oncology Account Executive
BillionToOne
Summary
We are looking for a field-based professional Oncology Account Executive, Wilmington NC with scientific and clinical expertise to support our oncology portfolio of liquid biopsy products. The position is responsible for driving sales volume for BillionToOne’s Northstar Liquid biopsy products and services, while cultivating relationships with oncologists and other members of the extended cancer care community in the designated geography. The Oncology Account Executive is a field based position and reports to a Regional Manager - Oncology.
Job description
Responsibilities
- Increasing revenue and driving market development through direct sales to individual Oncologists
- Creating and implementing a strategic business plan to grow revenue quickly in your geography
- Sales efforts include effective prospecting and cultivating new business and maintaining key relationships
Qualifications
- Bachelor's Degree or equivalent experience
- Demonstrated successful sales track record (e.g., Presidents club, Chairman's club, Rookie of the Year, or a history of success - at or above goal for multiple quarters/years)
- Experience selling to medical providers
- Experience selling medical diagnostics, medical or surgical devices
- Lives within the defined territory and centrally located to defined accounts
- Commitment to travel within defined territory
- Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
- Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
- Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically
- Must act with a sense of urgency, with a focus on closing business
- Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving
- Strong desire to work in a startup environment and must work independently with an internal drive to be successful
We will also consider candidates with the following backgrounds: Physicians Assistant (PA), Nurse Practitioner (NP) or Registered Nurse (RN) with experience ordering late stage cancer liquid biopsy tests
Requirements
- Bachelor's Degree or equivalent experience
- Demonstrated successful sales track record
- Experience selling to medical providers
- Experience selling medical diagnostics, medical or surgical devices
- Lives within the defined territory
- Commitment to travel within defined territory
- Excellent organizational and communication skills
- Effective time management skills
- Strong interpersonal and analytical skills
- Ability to think strategically and execute tactically
- Sense of urgency and focus on closing business
- Consultative sales and problem solving skills
- Ability to work independently in a startup environment
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Equity Options
- Paid Parental Leave
- Fertility Benefits
- Paid Time Off
- Hardware Provided
Company overview
BillionToOne is a precision diagnostics company headquartered in Menlo Park, California, founded in 2016 with a mission to make molecular diagnostics more accurate, efficient, and accessible. The company has developed a proprietary Quantitative Counting Templates (QCT) molecular counting platform that can accurately count DNA molecules at the single-molecule level, enabling unprecedented sensitivity in disease detection. BillionToOne operates as a publicly traded company on NASDAQ under the symbol BLLN, having completed a successful IPO in 2025. The company's diagnostic platforms include UNITY Complete for non-invasive prenatal testing, which assesses fetal risk for recessive conditions and aneuploidies from a single maternal blood sample, and Northstar oncology products for cancer therapy selection and treatment response monitoring. With over 500 employees and multiple CLIA/CAP accredited laboratories, BillionToOne represents a significant advancement in quantitative molecular diagnostics, combining breakthrough science with scalable commercial operations to transform healthcare delivery.